| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 9 | |
| #2 | EPO (European Patent Office) | 9 | |
| #3 | WIPO (World Intellectual Property Organization) | 8 | |
| #4 | Canada | 7 | |
| #5 | India | 6 | |
| #6 | Israel | 5 | |
| #7 | Poland | 5 | |
| #8 | Hungary | 4 | |
| #9 | Norway | 4 | |
| #10 | New Zealand | 4 | |
| #11 | African Regional Industrial Property Organization | 3 | |
| #12 | Brazil | 3 | |
| #13 | China | 3 | |
| #14 | EAPO (Eurasian Patent Organization) | 3 | |
| #15 | Yugoslavia (Serbia and Montenegro) | 3 | |
| #16 | Czechia | 2 | |
| #17 | United Kingdom | 2 | |
| #18 | Mexico | 2 | |
| #19 | African Intellectual Property Organization | 1 | |
| #20 | Slovakia | 1 | |
| #21 | Ukraine | 1 | |
| #22 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Medical technology | |
| #5 | Agriculture | |
| #6 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Microorganisms | |
| #6 | Animal care | |
| #7 | Unspecified technologies | |
| #8 | Heterocyclic compounds | |
| #9 | Object sterilising | |
| #10 | Implantable devices |
| # | Name | Total Patents |
|---|---|---|
| #1 | Satoh Yusuke | 14 |
| #2 | Kitamura Kazuyuki | 14 |
| #3 | Kawai Shinji | 14 |
| #4 | Doi Kazuyuki | 13 |
| #5 | Kimura Michio | 11 |
| #6 | Sakai Kunikazu | 10 |
| #7 | Honda Jun | 9 |
| #8 | Sugiura Takeyuki | 9 |
| #9 | Andou Hidetoshi | 8 |
| #10 | Takahashi Mikiko | 7 |
| Publication | Filing date | Title |
|---|---|---|
| YU28799A | Process for preparing purified dimer of bone-derived factor | |
| CN1242052A | Process for preparing purified dimer of bone-derived factor | |
| ZA9711580B | Process for the production of purified dimeric bone morphogenetic factors. | |
| GB9724777D0 | Intravaginal drug delivery device | |
| GB9713360D0 | Intravaginal drug delivery device | |
| CA2254857A1 | Anti-human mp52 monoclonal antibody | |
| HU9903273A3 | Anti-human mp52 monoclonal antibody | |
| HU9903006A3 | Process for producing maturation bone morphogenetic protein | |
| PL329610A1 | Method of obtaining mature morphogenetic bone protein | |
| EP0677289A2 | Pharmaceutical composition for treating osteoporosis | |
| EP0561297A2 | Tissue antigen and diagnostic method for human osteoporosis using the same |